Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM) -- Ignore unavailable to you. Want to Upgrade?

To: BostonView who wrote (431)	12/2/1999 7:38:00 PM
From: Biomaven	Read Replies (2) \| Respond to of 3044

I too have a low cost basis, averaging around $17. I first bought in 1997 at around $20, then added in 1998 at levels down to $15. I'm holding firmly. My view is that while in the short/medium term the stock may possibly be ahead of itself, and would be vulnerable if there is a biotech correction, in the long term this stock has a good chance to be one of the crown jewels of biotech. They certainly are one of the most ambitious of the biotechs, and their execution to date has been flawless. Both their science and their management is widely perceived as being as good as anything in biotechland. In the very short term, anything to do with genomics is red hot, and MLNM is as good a place to be as any to take advantage of this current craze. Hadn't followed the RS MLNM ratings. Who's their MLNM analyst - Mike King? My guess is that at very worst they'll give it an enthusiastic long term rec and a cautious short term one because of the price appreciation. (Kind of like what they did for CELG last week when initiating coverage). Peter

To: BostonView who wrote (431)	12/2/1999 8:10:00 PM
From: Mike Sesan	Respond to of 3044

It really depends if your long term. I am so buried in MLNM at $15 that I will probably hold for years with a low split adjusted cost that could come at anytime. This is a great stock due to the power of its alliances and its research capabilities. Its in my IRA so I have plenty of years to go. I believe alot of the spike we are getting could be due to a split announcement that could be anytime. Just my .02

To: BostonView who wrote (431)	12/2/1999 11:12:00 PM
From: Charles Holewinski	Read Replies (1) \| Respond to of 3044

With a PE over 140 and no products on the market yet one wonders how much further this one can go. But then in this crazy market we have today where the long term seems to be twenty years out MLNM seems to be perhaps the first stock to match the trees growing to the sky. I stumbled on to MLNM several months ago when I heard it recommended on the Nightly Business Report. At that time it was 35 and selling at a 52 week high. Liking the name Millennium Pharmaceuticals and the business it is in, I bought 500 shares the very next day. When it dropped to 66 on the announcement of its buy out of its only competitor I sold 300 shares. I intend to hold the remaining 200 shares forever. I just wish I had another 75 years of life left. Companies such as MLNM today are where GE was at the beginning of this century and MCD, IBM and others where when they first starting out. MLNM is one of those which in years to come will make millionaires of those who only bought 100 shares today. Many will say "If I had only bought MLNM." If there are any serious pull backs I intend to pick up more but at 100 and with a high PE I am very cautious here. I just thank fate that I was able to get in when I did. Perhaps I am too optimistic here but if this company is managed properly the products they will discover will cure health problems which have remained a mystery until now. For those who are a little nervous at the current 100 price I say sell enough to recover your purchase price. The remaining shares can be viewed as being free and holding them forever won't seem so reckless or cause stomach problems.